Evidence map›Paper›PMID 41636114›Full record

ArticleDalton transactions (Cambridge, England : 2003)2026

Hydroxyquinoline-functionalised aza-crown macrocycles for lanthanide coordination.

Christina Siakalli, Bradley E Osborne, Ryan K Brown, Claudia Rocco, Dominik Weiss, Enrique V García-España, Pascal V Grundler, Anzhelika N Moiseeva, Zeynep Talip, Nicholas P van der Meulen and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Dalton transactions (Cambridge, England : 2003), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Christina SiakalliDepartment of Chemistry, Imperial College London, Molecular Sciences Research Hub, White City Campus, London, W12 0BZ, UK. n.long@imperial.ac.uk.ORCID http://orcid.org/0000-0002-5505-5303
Bradley E OsborneDepartment of Chemistry, Imperial College London, Molecular Sciences Research Hub, White City Campus, London, W12 0BZ, UK. n.long@imperial.ac.uk.ORCID http://orcid.org/0000-0001-9663-8292
Ryan K BrownDepartment of Chemistry, Imperial College London, Molecular Sciences Research Hub, White City Campus, London, W12 0BZ, UK. n.long@imperial.ac.uk.
Claudia RoccoDepartment of Earth Science and Engineering, Imperial College London, South Kensington Campus, London, SW7 2BP, UK.
Dominik WeissDepartment of Earth Science and Engineering, Imperial College London, South Kensington Campus, London, SW7 2BP, UK.
Enrique V García-EspañaICMol, Departament de Química Inorgànica, Universitat de València, C/Catedrático José Beltrán 2, Paterna 46980, Spain.ORCID http://orcid.org/0000-0002-4601-6505
Pascal V GrundlerCenter for Radiopharmaceutical Sciences, PSI Center for Life Sciences, 5232 Villigen-PSI, Switzerland.
Anzhelika N MoiseevaCenter for Radiopharmaceutical Sciences, PSI Center for Life Sciences, 5232 Villigen-PSI, Switzerland.
Zeynep TalipLaboratory of Radiochemistry, PSI Center for Nuclear Engineering and Science, 5232 Villigen-PSI, Switzerland.
Nicholas P van der MeulenCenter for Radiopharmaceutical Sciences, PSI Center for Life Sciences, 5232 Villigen-PSI, Switzerland.
Michelle T MaSchool of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, London, SE1 7EH, UK. michelle.ma@kcl.ac.uk.ORCID http://orcid.org/0000-0002-3349-7346
Nicholas J LongDepartment of Chemistry, Imperial College London, Molecular Sciences Research Hub, White City Campus, London, W12 0BZ, UK. n.long@imperial.ac.uk.ORCID http://orcid.org/0000-0002-8298-938X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging therapeutic radiolanthanides have utility for systemic molecular radiotherapy in nuclear medicine, provided that suitable chemical technology is available to incorporate them into receptor-targeted radiopharmaceuticals. In this work,

Identifiers

PMID41636114
PMCPMC13591454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.